Term Name: EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
Synonyms: 2'-deoxyribonucleoside-diphosphate:thioredoxin-disulfide 2'-oxidoreductase inhibitor, 2'-deoxyribonucleoside-diphosphate:thioredoxin-disulfide 2'-oxidoreductase inhibitors, ADP reductase inhibitor, ADP reductase inhibitors, CDP reductase inhibitor, CDP reductase inhibitors, EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitors, EC 1.17.4.1 inhibitor, EC 1.17.4.1 inhibitors, nucleoside diphosphate reductase inhibitor, nucleoside diphosphate reductase inhibitors, ribonucleoside diphosphate reductase inhibitor, ribonucleoside diphosphate reductase inhibitors, ribonucleoside-diphosphate reductase (EC 1.17.4.1) inhibitor, ribonucleoside-diphosphate reductase (EC 1.17.4.1) inhibitors, ribonucleoside-diphosphate reductase inhibitor, ribonucleoside-diphosphate reductase inhibitors, ribonucleotide diphosphate reductase inhibitor, ribonucleotide diphosphate reductase inhibitors, ribonucleotide reductase inhibitor, ribonucleotide reductase inhibitors, RR inhibitor, RR inhibitors, UDP reductase inhibitor, UDP reductase inhibitors
Definition: An EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitor that inhibits the action of ribonucleoside-diphosphate reductase (EC 1.17.4.1).
Ontology: ChEBI [CHEBI:74213]  ( EBI )

Relationships
is a type of: EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitor
inverse has_role: gemcitabine gemcitabine hydrochloride guanazole hydroxyurea triapine